Literature DB >> 24094644

Dynamic volume perfusion CT in patients with lung cancer: baseline perfusion characteristics of different histological subtypes.

Jingyun Shi1, Gerald Schmid-Bindert, Christian Fink, Sonja Sudarski, Paul Apfaltrer, Lothar R Pilz, Bo Liu, Ulrike Haberland, Ernst Klotz, Caicun Zhou, Stefan O Schoenberg, Thomas Henzler.   

Abstract

OBJECTIVE: To evaluate dynamic volume perfusion CT (dVPCT) tumor baseline characteristics of three different subtypes of lung cancer in untreated patients.
MATERIALS AND METHODS: 173 consecutive patients (131 men, 42 women; mean age 61 ± 10 years) with newly diagnosed lung cancer underwent dVPCT prior to biopsy. Tumor permeability, blood flow (BF), blood volume (BV) and mean transit time (MTT) were quantitatively assessed as well as tumor diameter and volume. Tumor subtypes were histologically determined and compared concerning their dVPCT results. dVPCT results were correlated to tumor diameter and volume.
RESULTS: Histology revealed adenocarcinoma in 88, squamous cell carcinoma in 54 and small cell lung cancer (SCLC) in 31 patients. Tumor permeability was significantly differing between adenocarcinoma, squamous cell carcinoma and SCLC (all p<0.05). Tumor BF and BV were higher in adenocarcinomathan in SCLC (p = 0.001 and p=0.0002 respectively). BV was also higher in squamous cell carcinoma compared to SCLC (p = 0.01). MTT was not differing between tumor subtypes. Regarding all tumors, tumor diameter did not correlate with any of the dVPCT parameters, whereas tumor volume was negatively associated with permeability, BF and BV (r = -0.22, -0.24, -0.24, all p<0.05). In squamous cell carcinoma, tumor diameter und volume correlated with BV (r = 0.53 and r = -0.40, all p<0.05). In SCLC, tumor diameter und volume correlated with MTT (r = 0.46 and r = 0.39, all p<0.05). In adenocarcinoma, no association between morphological and functional tumor characteristics was observed.
CONCLUSIONS: dVPCT parameters are only partially related to tumor diameter and volume and are significantly differing between lung cancer subtypes.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Dynamic volume perfusion CT; Functional imaging; Lung cancer; Tumor angiogenesis

Mesh:

Year:  2013        PMID: 24094644     DOI: 10.1016/j.ejrad.2013.08.023

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  11 in total

Review 1.  What scans we will read: imaging instrumentation trends in clinical oncology.

Authors:  Thomas Beyer; Luc Bidaut; John Dickson; Marc Kachelriess; Fabian Kiessling; Rainer Leitgeb; Jingfei Ma; Lalith Kumar Shiyam Sundar; Benjamin Theek; Osama Mawlawi
Journal:  Cancer Imaging       Date:  2020-06-09       Impact factor: 3.909

2.  Iodine concentration as a perfusion surrogate marker in oncology: Further elucidation of the underlying mechanisms using Volume Perfusion CT with 80 kVp.

Authors:  Wolfgang M Thaiss; Ulrike Haberland; Sascha Kaufmann; Daniel Spira; Christoph Thomas; Konstantin Nikolaou; Marius Horger; Alexander W Sauter
Journal:  Eur Radiol       Date:  2015-12-17       Impact factor: 5.315

3.  The application of dual-layer spectral detector computed tomography in solitary pulmonary nodule identification.

Authors:  Qingyun Wen; Yong Yue; Jin Shang; Xiaomei Lu; Lu Gao; Yang Hou
Journal:  Quant Imaging Med Surg       Date:  2021-02

4.  Computed tomography perfusion (CTP) in primary lung cancer: Results from a tertiary care centre.

Authors:  Mufeed Arimbrakkunnan; Pawan K Garg; Pushpinder S Khera; Binit Sureka; Poonam Elhence; Puneet Pareek; Nishant Kumar Chauhan; Taruna Yadav
Journal:  Lung India       Date:  2022 May-Jun

5.  Implementation of a phase detection algorithm for dynamic cardiac computed tomography analysis based on time dependent contrast agent distribution.

Authors:  Carsten Kendziorra; Henning Meyer; Marc Dewey
Journal:  PLoS One       Date:  2014-12-29       Impact factor: 3.240

6.  Assessing the Blood Supply Status of the Focal Ground-Glass Opacity in Lungs Using Spectral Computed Tomography.

Authors:  Guanfu Liu; Mengying Li; Guosheng Li; Zhiyong Li; Ailian Liu; Renwang Pu; Huizhi Cao; Yijun Liu
Journal:  Korean J Radiol       Date:  2018-01-02       Impact factor: 3.500

7.  Dual-input tracer kinetic modeling of dynamic contrast-enhanced MRI in thoracic malignancies.

Authors:  Sang Ho Lee; Andreas Rimner; Joseph O Deasy; Margie A Hunt; Neelam Tyagi
Journal:  J Appl Clin Med Phys       Date:  2019-10-11       Impact factor: 2.102

8.  Multiparametric imaging of patient and tumour heterogeneity in non-small-cell lung cancer: quantification of tumour hypoxia, metabolism and perfusion.

Authors:  Wouter van Elmpt; Catharina M L Zegers; Bart Reymen; Aniek J G Even; Anne-Marie C Dingemans; Michel Oellers; Joachim E Wildberger; Felix M Mottaghy; Marco Das; Esther G C Troost; Philippe Lambin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-09-04       Impact factor: 9.236

9.  Thick-wall cavity predicts worse progression-free survival in lung adenocarcinoma treated with first-line EGFR-TKIs.

Authors:  Fei Zhou; Wanrong Ma; Wei Li; Huijuan Ni; Guanghui Gao; Xiaoxia Chen; Jie Zhang; Jingyun Shi
Journal:  BMC Cancer       Date:  2018-10-23       Impact factor: 4.430

10.  CT Perfusion in Patients with Lung Cancer: Squamous Cell Carcinoma and Adenocarcinoma Show a Different Blood Flow.

Authors:  Alessandro Bevilacqua; Giampaolo Gavelli; Serena Baiocco; Domenico Barone
Journal:  Biomed Res Int       Date:  2018-09-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.